Targeting the Endocannabinoid System Through a 3 Layered Approach
ECS Therapy is pioneering a new category of Endocannabinoid System (ECS) Supplements designed to support the body’s master regulatory system through targeted combinations of cannabinoids, terpenes, and complementary botanical compounds, amino acids, and minerals.
Support the system – not just a couple signal pathways.
Bottle Size: 100 mL
Designed for localized comfort support.
This advanced topical uses a pharmaceutical-grade DMSO deep-penetration delivery system to help active compounds reach underlying tissue where ECS receptors exist within the skin and peripheral nervous system.
DMSO is widely studied for its ability to enhance transdermal delivery and has also demonstrated intrinsic comfort-support properties, making it uniquely suited for advanced topical formulations.
Total cannabinoids: 8,000 mg
Pain Support Terpene Blend – Beta Caryophyllene,Geraniol, Sabinene, Delta-3 Carene, Nerolidol Botanical Complex Total MG 5000 – Ultra-Micronized Palmitoylethanolamide (PEA) and MSM
ECS Therapy began with a deeply personal mission.
Jerry Flowers began studying the Endocannabinoid System while searching for ways to support his mother’s health challenges.
She was diagnosed with colon cancer in 2010 and pancreatic cancer in 2012.
She ultimately became the first person he formulated for, helping shape the approach that would later become the foundation of ECS Therapy.
Through years of research and real-world collaboration, more than 2,000 formulations were developed through evaluation and feedback.
The formulations in Phase 1 represent more than eight years of research, formulation development, and real-world evaluation before being prepared for release.
Every ECS Therapy formulation is developed through a structured process combining research, formulation science, and real-world evaluation.
Based on this feedback, the formulation is adjusted to improve effectiveness or balance as new research and insights emerge.
This cycle of refinement continues until both the evaluator and the formulator determine that further adjustments are no longer necessary.
Once the evaluator is satisfied, the formulation is introduced to additional participants through the dispensary to gather broader real-world feedback and continues to be refined until it passes final validation.
If 80% or more participants report at least 8/10 positive feedback in the targeted support areas without adverse side effects, the formulation is considered ready and may move forward as an ECS Therapy supplement.
Give yourself 7 days to discover what ECS support feels like.
The ECS Therapy 7-Day evaluation program allows individuals to explore how Endocannabinoid System (ECS) supplements may support their body’s natural balance at a low risk.
Experience the difference supporting your ECS feels versus chasing symptoms.
Evaluation Guidance – Each 7-Day sample comes with an evaluation card to track your results
Save 15% + Free Shipping
$67.15
No commitment
$79.00
30-day money-back guarantee. Cancel any time.
Before ECS Therapy existed as a brand, UWD’s clients and families worked closely with Jerry Flowers while exploring formulations designed to support the Endocannabinoid System.
Their patience, trust, and feedback helped shape the formulations that would later become ECS Therapy.
Here are just a few of their journeys.
These individuals helped refine many of the formulations that later became the ECS Therapy system.
To develop cannabinoid-centered support systems grounded in endocannabinoid science-designed to help individuals pursue comfort, composure, and recovery through disciplined formulation, not trend-based supplements.
To become the most trusted name in systems-based cannabinoid wellness-where transparency, research, and real-world refinement guide every release, and every customer can evaluate with confidence.
Our journey began with family health challenges, inspiring our exploration of plant-based science.
Over 100 hours of cannabinoid education and research shaped our formulation philosophy.
Our work centers on the endocannabinoid system (ECS), the body’s balance-regulating network.
We follow a research-first approach, selecting ingredients for safety and compatibility.
Despite its critical role in maintaining balance and regulating core functions, the Endocannabinoid System (ECS) remains largely overlooked in modern healthcare and education.
The ECS is one of the most recently identified biological systems, discovered through cannabinoid research in the 20th century.
Around 85% of U.S. medical schools do not include ECS education—highlighting a major gap in clinical awareness.
Named after cannabis, the ECS has long been misunderstood due to decades of stigma and prohibition.
Unlike traditional systems, the ECS operates through receptors and enzymes throughout the body, making it harder to study and teach.
Multi-pathway composure support designed to help regulate stress response and promote steady emotional balance throughout the day.
Multi-pathway composure support designed to help regulate stress response and promote steady emotional balance throughout the day.
Multi-pathway composure support designed to help regulate stress response and promote steady emotional balance throughout the day.
Multi-pathway composure support designed to help regulate stress response and promote steady emotional balance throughout the day.
A disciplined process designed to ensure every ECS Therapy formulation is grounded in research, refined through experience, and released only when performance and balance align.
We begin by evaluating peer-reviewed literature using PubMed and other scientific databases.
Formulations undergo multiple iterations during development to refine balance and improve consistency.
Only when performance, balance, and usability align does a formula move to production.
Individuals exploring ECS Therapy formulations often share their experiences with balance, recovery, and everyday resilience. Here are a few insights from real-world use.
Every formula is developed with a commitment to science, safety, and consistency — combining years of research, independent testing, THC-free standards, and an ECS-focused formulation approach.
Wellness Research Enthusiast
I began researching the endocannabinoid system after struggling with persistent discomfort. ECS Therapy’s approach felt thoughtful and research-driven. Over time, I noticed more consistency in how my body responded to stress and daily activity
Health & Lifestyle Advocate
I began researching the endocannabinoid system after struggling with persistent discomfort. ECS Therapy’s approach felt thoughtful and research-driven. Over time, I noticed more consistency in how my body responded to stress and daily activity
Wellness Research Enthusiast
I began researching the endocannabinoid system after struggling with persistent discomfort. ECS Therapy’s approach felt thoughtful and research-driven. Over time, I noticed more consistency in how my body responded to stress and daily activity
Wellness Research Enthusiast
These statements have not been evaluated by the Food
and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease. Consult your physician before use if you are
pregnant, nursing, or taking any medication.
© 2026 ECS Therapy. All Copyright Reserved – Design By Bmybrand